CTX — Captor Therapeutics SA Cashflow Statement
0.000.00%
Last trade - 00:00
- PLN364.22m
- PLN292.30m
- PLN13.20m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -8.31 | -12.7 | -32.6 | -35.9 | -70.6 |
Depreciation | |||||
Non-Cash Items | 0.55 | 1.75 | 9.53 | 7.89 | 4.46 |
Other Non-Cash Items | |||||
Changes in Working Capital | 7.69 | 3.75 | -12.8 | -2.04 | 8.48 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4.39 | -0.595 | -28.5 | -22.9 | -52.2 |
Capital Expenditures | -0.229 | -0.212 | -5.11 | -0.892 | -3 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | -16.7 | 22.9 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.229 | -0.212 | -5.11 | -17.6 | 19.9 |
Financing Cash Flow Items | — | — | -0.409 | -0.575 | -0.318 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.73 | -0.881 | 141 | -6.33 | 36.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.89 | -1.69 | 107 | -46.9 | 4.67 |